BMJ Open

Temporal trends in single and multiple organ fibrosis prevalence and primary care consultations: a population-based cohort study of 5.8 million individuals in England

Figure 1. Prevalence of fibrotic conditions between 2012 and 2022.
Open the figure at full size
Figure 1. Prevalence of fibrotic conditions between 2012 and 2022.Prevalence of fibrotic conditions between 2012 and 2022.Massen et al.
Cohort study of 18,784,962 peoplePopulations

Declared ties to: AstraZeneca, Biogen, Genentech and 24 more

The paper